Overview

Effect of GLP - 1 (7-36 Amide) on Myocardial Function Following Coronary Artery Bypass (CABG) Surgery

Status:
Terminated
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
This research is being done to see if giving a hormone called GLP-1 can improve heart function and reduce length of stay in the Cardiac Surgical Intensive Care Unit (CSICU) in people who have non-emergent coronary artery bypass graft (CABG) surgery.
Phase:
Phase 2
Details
Lead Sponsor:
Johns Hopkins University
Treatments:
Glucagon
Glucagon-Like Peptide 1